IRCT20191217045765N1 IRCT 2020-02-09 Zahedan University of Medical Sciences Effect of Zinc sulfate in Diabetic Hemodialysis patients Effect of Zinc sulfate consumption on serum Galectin-3 level in Diabetic Hemodialysis patients 2019-12-22 anticipated 40 Complete https://irct.ir/trial/44365 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Diabetic Hemodialysis patients with inclusion criteria enter as available. Then they will be divided into two groups(case and control) using the file number through random variable, Blinding description: Randomization and allocation will hide from the researcher and patients until the main analyses were completed. 3 Diabetic Hemodialysis. Intervention 1: Intervention group1: The zinc-supplementation group(n=20) will receive a 220-mg Zinc sulfate capsule (containing 50 mg zinc) manufactured by Alhavi Pharmaceutical Company (Tehran, Iran); for 56 days. Intervention 2: Control group:The control-group(n=20) will receive a placebo capsule(220-mg corn starch), for 56 days. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Not enough information